El programa del B·Debate, en imatges
![](https://barcelonamaculafound.org/wp-content/uploads/2016/09/B·Debate-web.jpg)
SESSION 1: MOLECULAR PATHOLOGY AND BIOMARKERS IN AGE-RELATED MACULAR DEGENERATION (AMD)
Macular degeneration. Where we are in clinical practice, J.Monés.
![Jordi Monés, ponent.](http://barcelonamaculafound.org/wp-content/uploads/2016/09/Mones2-1024x574.jpg)
Jordi Monés (Barcelona Macula Foundation: Research for Vision).
Anti PDGF therapy for exudative AMD: addressing the fibrosis pathway, S.Patel.
![Samir Patel (Ophthotec).](http://barcelonamaculafound.org/wp-content/uploads/2016/09/Fighting-Blidness-029-725x1024.jpg)
Samir Patel (Ophthotech).
Markers and Mechanisms in Maculopathies: a systems view, M.Ueffing.
![](http://barcelonamaculafound.org/wp-content/uploads/2016/09/Ueffing-2-1-1024x574.jpg)
Marius Ueffing (Institute for Ophthalmic Research Tübingen).
Towards a systems-oriented view of the molecular pathology of AMD, C.Kiel.
![Christina Kiel (Centre for Genomic Regulation, CRG).](http://barcelonamaculafound.org/wp-content/uploads/2016/09/Kiel-1024x574.jpg)
Christina Kiel (Centre for Genomic Regulation, CRG).
Cellular response associated to retinal diseases and therapeutics approaches, N.Cuenca.
![Nicolás Cuenca (Universidad de Alicante). Foto: Jordi Moner.](http://barcelonamaculafound.org/wp-content/uploads/2016/09/Fighting-Blidness-045-1024x683.jpg)
Nicolás Cuenca (Universidad de Alicante). Foto: Jordi Moner.
KEYNOTE SPEAKER: A molecular road to a therapy for Dry AMD, J.Ambati.
![Jayakrishna Ambati (New Jersey Medical School).](http://barcelonamaculafound.org/wp-content/uploads/2016/09/Ambati-1024x574.jpg)
Jayakrishna Ambati (University of Kentucky).
SESSION 2: NANOTECHNOLOGY
Medical Nanochemistry, the use of reactive inorganic nanoparticles in medicine, V.Puntes.
![](http://barcelonamaculafound.org/wp-content/uploads/2016/09/Víctor-Puntes1-1024x574.jpg)
Víctor Puntes (Vall d’Hebron Institute of Research, VHIR).
Non-viral gene delivery for the treatment of inherited retinal disorders, G.Puras Ochoa.
![Gustavo Puras Ochoa (Universidad del País Vasco).](http://barcelonamaculafound.org/wp-content/uploads/2016/09/Gustavo-Puras-Ochoa-2-1024x574.jpg)
Gustavo Puras Ochoa (Universidad del País Vasco).
Retinal degenerations: Animal models and new therapeutical approaches, G.Martínez Navarrete.
![Gema Martínez Navarrete (Universidad Miguel Hernández).](http://barcelonamaculafound.org/wp-content/uploads/2016/09/Gema-Martínez-Navarrete-1024x574.jpg)
Gema Martínez Navarrete (Universidad Miguel Hernández).
SESSION 3: GENETICS AND GENE THERAPY
Genetics. The case of the EYE RISK project. C.Klaver.
![Caroline Klaver (Erasmus University).](http://barcelonamaculafound.org/wp-content/uploads/2016/09/Caroline-Klaver-1024x574.jpg)
Caroline Klaver (Erasmus University).
The role of mithocondrial genetics on the development of AMD, B.Kupperman.
![Baruch D. Kupperman (University of California).](http://barcelonamaculafound.org/wp-content/uploads/2016/09/Kupermann-1024x574.jpg)
Baruch D. Kupperman (University of California).
Gene therapy in retinal degenerative diseases, looking for therapeutic targets, F.Díaz Corrales.
![Francisco Díaz Corrales (Centro Andaluz de Biología Molecular y Medicina Regenerativa, CABIMER).](http://barcelonamaculafound.org/wp-content/uploads/2016/09/Francisco-Díaz-Corrales-1024x574.jpg)
Francisco Díaz Corrales (Centro Andaluz de Biología Molecular y Medicina Regenerativa, CABIMER).
SESSION 4: PHOTONICS AND IMAGING
The use of advanced microscopy techniques for ophthalmological applications, P.Loza.
![Pablo Loza (Institute of Photonic Sciences, ICFO).](http://barcelonamaculafound.org/wp-content/uploads/2016/09/Pablo-Loza-1024x574.jpg)
Pablo Loza (Institute of Photonic Sciences, ICFO).
High resolution retinal imaging: the case of LITE project, D.Merino.
![David Merino (Institute of Photonic Sciences).](http://barcelonamaculafound.org/wp-content/uploads/2016/09/David-Merino-1024x574.jpg)
David Merino (Institute of Photonic Sciences).
From taking a PEEK to wide-field imaging: how imaging best serves translational research?, T.Peto.
![Tunde Peto (University College London).](http://barcelonamaculafound.org/wp-content/uploads/2016/09/Tunde-Peto-1024x575.jpg)
Tunde Peto (University College London).
SESSION 5: OPTOGENETICS AND ARTIFICIAL VISION
Visual neuroprosthesis: Current status and future prospects, E.Fernández.
![Eduardo Fernández (Universidad Miguel Hernández).](http://barcelonamaculafound.org/wp-content/uploads/2016/09/Eduardo-Fernández-1024x574.jpg)
Eduardo Fernández (Universidad Miguel Hernández).
KEYNOTE SPEAKER: OPTOGENETICS, M.Zarbin.
![Marco Zarbin (Rutgers New Jersey Medical School).](http://barcelonamaculafound.org/wp-content/uploads/2016/09/Zarbin-1024x574.jpg)
Marco Zarbin (Rutgers New Jersey Medical School).
SESSION 6: REGENERATIVE THERAPY. STEM CELLS
Advanced cell therapies for AMD, B.de la Cerda Haynes.
![Berta de la Cerda Haynes (Centro Andaluz de Biología Molecular y Medicina Regenerativa, CABIMER).](http://barcelonamaculafound.org/wp-content/uploads/2016/09/Berta-de-la-Cerda-1024x574.jpg)
Berta de la Cerda Haynes (Centro Andaluz de Biología Molecular y Medicina Regenerativa, CABIMER).
Pluripotent stem cells for retinal disease, research and clinical application, A.Veiga.
![Anna Veiga (Centre de Medicina Regenerativa de Barcelona, CMRB).](http://barcelonamaculafound.org/wp-content/uploads/2016/09/Anna-Veiga-1024x574.jpg)
Anna Veiga (Centre de Medicina Regenerativa de Barcelona, CMRB).
Use of induced pluripotent stem cells and direct lineage reprogramming in cell therapy for eye regenerative medicine, B.Álvarez.
![Ana Belén Álvarez (Universitat de Barcelona).](http://barcelonamaculafound.org/wp-content/uploads/2016/09/Ana-Belén-Álvarez-1024x574.jpg)
Ana Belén Álvarez (Universitat de Barcelona).
Improving the quality and characterisation of stem cell reprogramming and analysing the genomic stability and immune response, M.Edel.
![Michael Edel (Universitat de Barcelona).](http://barcelonamaculafound.org/wp-content/uploads/2016/09/Michael-Edel-1024x574.jpg)
Michael Edel (Universitat de Barcelona).
Adult progenitor stem cells: applications for cell-based therapy in degenerative retinal diseases, R.Casaroli.
![Ricardo Casaroli (Institut Clínic d'Oftalmologia, ICOF).](http://barcelonamaculafound.org/wp-content/uploads/2016/09/Ricardo-Casaroli-1024x574.jpg)
Ricardo Casaroli (Institut Clínic d’Oftalmologia, ICOF).
Retinal regeneration via cell fusion mediated reprogramming, P.Cosma.
![Pia Cosma (Centre for Genomic Regulation, CRG).](http://barcelonamaculafound.org/wp-content/uploads/2016/09/Pia-Cosma-1024x574.jpg)
Pia Cosma (Centre for Genomic Regulation, CRG).
SESSION 7: ROUND TABLE. FROM BENCH TO BEDSIDE
KEYNOTE SPEAKER: HIV brought us to Microbiome study, B.Clotet.
![Bonaventura Clotet (Institut de Recerca de la Sida, IrsiCaixa).](http://barcelonamaculafound.org/wp-content/uploads/2016/09/Bonaventura-Clotet-1024x574.jpg)
Bonaventura Clotet (Institut de Recerca de la Sida, IrsiCaixa).
Research transfer, X.Rubíes.
![Xavier Rubíes Feijoo (Institut de Bioenginyeria de Catalunya, IBEC).](http://barcelonamaculafound.org/wp-content/uploads/2016/09/Xavier-Rubies-1024x574.jpg)
Xavier Rubíes Feijoo (Institut de Bioenginyeria de Catalunya, IBEC).
Technology transfer, S.Artigas.
![Sergi Artigas (Centre Tecnològic LEITAT).](http://barcelonamaculafound.org/wp-content/uploads/2016/09/Sergi-Artigas-1024x574.jpg)
Sergi Artigas (Centre Tecnològic LEITAT).
Innovative schemes though demand-driven procurement for procuring early detection services: the case of the PRo4VIP, R.Maspons.
![Ramon Maspons (Agència de Qualitat i Avaluació Sanitàries de Catalunya, AQuAS).](http://barcelonamaculafound.org/wp-content/uploads/2016/09/Ramon-Maspons-1024x574.jpg)
Ramon Maspons (Agència de Qualitat i Avaluació Sanitàries de Catalunya, AQuAS).